Traitement actuel de l’amylose AL
Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Guy Touchard(Centre Hospitalier Universitaire de Poitiers), Éric Moumas(Inserm), Sébastien Delbès(Université de Poitiers), Frank Bridoux(Université de Poitiers), Jean‐Paul Fermand(Sorbonne Université), Julie Abraham(Centre Hospitalier Universitaire de Limoges), Laurence Lacotte‐Thierry(Centre Hospitalier Universitaire de Poitiers)
Cited by 2
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809